InvestorsHub Logo
icon url

NorthTrail

01/12/21 2:54 AM

#72764 RE: strippa #72763

thanks, strippa. any feedback passed on from the principals is appreciated. imo the whole deal banks on dd exporting a shelf-ready, double-encapsulated high-bioavailability product from this harvest. cyios' site already sells 5x more bioavailable cbd, probably from a 3rd party with ip that's new, but significantly inferior to txtm's. its tincture-only. txtm's double-encapsulation ip is probably necessary to deliver high bioavailability in capsule or gelcap. maybe dd will post harvest photos when able.

Humble conjecture and opinion, based on what's publicly available.

GLTA!!